A novel echocardiographic risk score predicts prognosis in AL-amyloidosis

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Paul Geenty

University of Sydney, Westmead (Australia)

7 More presentations in this session

Presentation thumbnail

Could echocardiographic left atrial characterization have additive value for detecting risks of atrial arrhythmias and stroke in patients with hypertrophic cardiomyopathy?

Mr A. Al wazzan (Rennes, FR)

Abstract Slides

Presentation thumbnail

Echocardiographic assessment of left ventricular radial strain to differentiate cardiac amyloidosis from Fabry disease

Mr T. Steudel (Berlin, DE)

Abstract Slides

Presentation thumbnail

Reduced 3D-left atrium ejection fraction predicts development of atrial fibrillation in patients with hypertrophic cardiomyopathy

Doctor A. Amador (Porto, PT)

Abstract Slides

Presentation thumbnail

Quantification of systolic anterior motion of the mitral valve to predict left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy

Doctor D. Zach (Salzburg, AT)

Abstract Slides

Presentation thumbnail

Right ventricular longitudinal contractility mismatch: a novel diagnostic marker of right ventricular arrhythmogenic cardiomyopathy

Doctor P. Bocchino (Turin, IT)

Abstract Slides

Access the full session

Session thumbnail

Risk stratification of cardiomyopathies with echocardiography

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Echocardiography as first-line technique in suspected cardiac amyloidosis

Congress Presentation

Dilated cardiomyopathy

Congress Session

Recent advances in clinical practice guidelines: what the imager needs to know and apply - Part 2

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources